Last reviewed · How we verify

NCT05170386

Cognitive Training on Sleeping Disorders in Stroke

Completed NA Last updated 14 January 2025
What this trial tests

NA trial testing Cognitive training Therapy in Stroke in 40 participants. Completed in 30 September 2024.

Timeline
1 April 2024
Primary endpoint
30 September 2024
30 September 2024

Quick facts

Lead sponsorOctober 6 University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment40
Start date1 April 2024
Primary completion30 September 2024
Estimated completion30 September 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

October 6 University

Who can join

Adults 40 to 55, any sex, with Stroke or Sleep Disorder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Cognitive impairment and sleeping disturbance following stroke diagnosis are common symptoms that significantly affect the quality of life.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Sleep disorders as both risk factors for, and a consequence of, stroke: A narrative review.
    Mayer-Suess L, Ibrahim A, Moelgg K, Cesari M, et al · · 2024 · cited 25× · PMID 37885093 · DOI 10.1177/17474930231212349

Verify or expand the search:

Other recruiting trials for Stroke

Currently open trials in the same condition.

Other October 6 University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05170386.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing